Tavanta Therapeutics
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| TAVT-45 (Abiraterone Acetate) Granules in Patients With Prostate Cancer (NCT04887506) | Tavanta Therapeutics | 2021-05-05 |
Track Tavanta Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.